Green Vitality dba Gr33n – 710151

by Pill Pals Customer Service | Sep 2, 2025 | News

Delivery Method: Via Email Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTERAugust 25, 2025RE: 710151Dear Privacy Compliance Officer:This letter is to advise you that the U.S. Food and Drug Administration (FDA)...

FDA-TRACK: Prescription Drug User Fee Act Review Goals Summary

by Pill Pals Customer Service | Sep 2, 2025 | News

The Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the Prescription Drug User Fee Act of 2022 (PDUFA VII), authorizes FDA to assess and collect fees for prescription drug products from October 2023 through September 2027. FDA dedicates these...

Homeopathic Educational Services dba Homeopathic Family Medicine – 708635

by Pill Pals Customer Service | Sep 2, 2025 | News

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Dana Ullman Homeopathic Educational Services dba Homeopathic Family Medicine 812Camelia Street, Suite CBerkeley, CA 94710-1418United States email@homeopathic.com Issuing Office: Center for Drug...

FDA-TRACK: Prescription Drug User Fee Act Procedural Goals Summary

by Pill Pals Customer Service | Sep 2, 2025 | News

The Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the Prescription Drug User Fee Act of 2022 (PDUFA VII), authorizes FDA to assess and collect fees for prescription drug products from October 2023 through September 2027. FDA dedicates these...

My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD – 712052

by Pill Pals Customer Service | Sep 2, 2025 | News

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Bingbing Feng My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD 2452 Gillingham CircleThousand Oaks, CA 91362United States support@myholistichoney.com Issuing Office: Center for...

FDA-TRACK: Prescription Drug User Fee Act Meeting Goals Summary

by Pill Pals Customer Service | Sep 2, 2025 | News

The Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the Prescription Drug User Fee Act of 2022 (PDUFA VII), authorizes FDA to assess and collect fees for prescription drug products from October 2023 through September 2027. FDA dedicates these...